FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
LALPATHLAB
1,999.65
+23.7 (1.2%)
Updated 03:28 18/09 IST
LALPATHLAB Buy or Sell - FrontPage Forums
0 Users have submitted 0 trade ideas of Rs. 0 for LALPATHLAB
Disclaimer0% Bullish
0% Bearish
LALPATHLAB Buy or Sell - Brokerage Reports
No. of reports in last year
3
No. of analysts
1
Average Consensus Forecast
1232.67
Consensus Potential
-75.72%
LALPATHLAB Ratings
Long term LALPATHLAB rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
3.5/5 (2 Ratings)
Find answers to all your questions on live LALPATHLAB message board: Is LALPATHLAB buy or sell? Should I buy LALPATHLAB shares? Why are LALPATHLAB shares falling? Should I invest in LALPATHLAB stock?
- Home
- LALPATHLAB Forum
LALPATHLAB Share Price Discussion
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
- keyboard_arrow_down
LALPATHLAB Share Price - Technicals
- NewsBotSep 5 10:11 AM
Reopening of economy, increased testing, no mask use led to rise in COVID-19 cases in Delhi: ExpertsThe Economic TimesNewsBotAug 9 2:38 AM
Hold Dr. Lal PathLabs; target of Rs 1995: GeojitMoneycontrolNewsBotAug 8 6:13 AM
Sell Dr. Lal PathLabs; target of Rs 1006: Prabhudas LilladherMoneycontrolNewsBotJul 31 9:56 AM
Dr Lal PathLabs Q1 results: Net profit declines 52% to Rs 28.4 croreThe Economic TimesNewsBotJul 31 8:43 AM
Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 croreMoneycontrolNewsBotJul 15 7:38 AM
Dr Lal PathLabs shares hit fresh all-time high; analysts positive on firm's long term storyMoneycontrolNewsBotJul 7 10:08 AM
Outlook for diagnostics industry favourable for growth: Dr Lal PathLabsMoneycontrolNewsBotJul 7 9:36 AM
Outlook for diagnostics industry favourable for growth: Dr Lal PathLabsThe Economic TimesNewsBotMay 19 4:43 AM
Sell Dr. Lal PathLabs; target of Rs 895: Prabhudas LilladherMoneycontrolNewsBotMay 9 1:43 AM
Opportunity is pharma is huge, advise investors to invest: Motilal OswalMoneycontrol
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.